EPCA-2 in the early diagnosis of prostate cancer].

Department of Urology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China. ydsxinyi@163.com

Zhonghua nan ke xue = National journal of andrology 2010 Jun

filter terms:

More and more clinical evidence has confirmed the limitations of the use of serum PSA in the screening, detection and treatment of prostate cancer, and scientists are continuously seeking for new biomarkers of the disease. The discovery of early prostate cancer antigen 2 (EPCA-2) has provided a new base for the screening, detection, treatment and follow-up of prostate cancer.

Citation

De-Shui Yu, Zhuo-Qun Xu. EPCA-2 in the early diagnosis of prostate cancer]. Zhonghua nan ke xue = National journal of andrology. 2010 Jun;16(6):552-5